Thuy Doan

Credentials: · · · · ·

History

Paucibacterial Microbiome and Resident DNA Virome of the Healthy Conjunctiva
Investigative Ophthalmology & Visual Science · 2016 · First of 10 authors · 191 citations
Illuminating uveitis: metagenomic deep sequencing identifies common and rare pathogens
Genome Medicine · 2016 · First of 13 authors · 160 citations
Macrolide and Nonmacrolide Resistance with Mass Azithromycin Distribution
New England Journal of Medicine · 2020 · First of 17 authors · Corresponding · 158 citations

AMR Monitoring to Improve Child’s Health and Mortality
National Institute of Allergy and Infectious Diseases · R01
Contact PI · $597.4K · University of California, San Francisco
2026–2031
Multi-Omics Strategies to Improve Clinical Outcomes in Uveitis
National Eye Institute · R01
Contact PI · $944.7K · University of California, San Francisco
2024–2029
Programmable Phage Display Peptidomes to Characterize Uveitis
National Eye Institute · R21
Contact PI · $451K · University of California, San Francisco
2024–2027
Seasonal Conjunctivitis Outbreak Reporting for Prevention and Improved Outcomes (SCORPIO)
National Eye Institute · R01
Contact PI · $2M · University of California, San Francisco
2021–2027

Ocular Pathogen and Transcriptome Investigation Using Comprehensive Sequencing
Principal investigator · Completed
University of California, San Francisco
2022–2024
Antibiotic Resistance In Eye Surgeries
Principal investigator · Completed · Phase 4
University of California, San Francisco
2021–2023
Azithromycin for COVID-19 Treatment in Outpatients Nationwide
Principal investigator · Terminated · Phase 3
Thomas M. Lietman
2020–2021
Azithromycin for Meibomian Gland Disease
Principal investigator · Terminated · Phase 4
University of California, San Francisco
2019–2021